LI
LianBio
LIANY · OTC
$0.06 +0.00% (+$0.00)
1M +80.30%
Market Cap $6.49M
P/E Ratio 1.32x
Div. Yield -
ROE -
Bulios Fair Price
$0.08
34.5% upside
Current Price
$0.06
Undervalued Fair Value Overvalued
According to Bulios Fair Price, LIANY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/E 1.32x
P/B 0.32x
P/FCF 1.31x
Growth
0 /100
Declining Book val. growth 57.11%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
21 /100
Poor ROIC 6.19%
ROA 23.93%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 1,466.01x
Int. coverage N/A
Stability
11 /100
Unstable Beta 0.07x
EPS volatility 241.61%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LIANY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Adam Leo Stone
Employees
163
Headquarters
Princeton
Upcoming events
17 NOV
Earnings
Upcoming earnings report